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Neurobiology of Pediatric Mood Disorders: 
Are We There Yet?
Jair C. Soares, M.D. and Jean A. Frazier, M.D.
549
THIS ISSUE OF Journal of Child and Adolescent Psychophrma-cology contains Part I of a two-part special issue on “Neu-
robiology of Pediatric Mood Disorders.” Some of the pio-
neers and leading clinical scientists working in this field have
contributed their work to this project. We are delighted to
have their outstanding contributions to this important series.
Contrary to past beliefs, we now know that mood disor-
ders are prevalent in childhood and adolescence. In these
age groups, unfortunately, both bipolar and unipolar mood
disorders often go undiagnosed for years. We have come a
long way as a field as far as being able to recognize these
disorders early. Over the past few years, our field has in-
creasingly been able to take advantage of new knowledge
and developments from clinical neurosciences to begin to
probe specific mechanisms and think about etiology and
pathophysiology of these severe mental illnesses throughout
childhood and adolescence.
Are these conditions originating from faulty neurodevel-
opment, or do they relate primarily to how our brains and
bodies react to various stressors? Are they to some extent
neurodegenerative? While no final answers are available,
there is a growing consensus that the etiology may lie in the
complex interface between a genetic vulnerability, likely con-
ferred by several genes, and environmental stressors—per-
haps with more impact during key periods of brain devel-
opment.
The present issue provides a nice illustration of some of
the emerging work. Three of the papers (Chen et al., Jarvis
et al., and Patel et al.) focus on neuroanatomical and neuro-
chemical abnormalities in unipolar and bipolar disorder chil-
dren, including the role of specific substance abuse comor-
bidities (Jarvis et al.). Other papers presented here focus on
the phenomenology, including comorbid conditions that
may be related neurobiologically, like attention-deficit/hy-
peractivity disorder (ADHD), as they occur so frequently in
mood disorders in this age range (Daviss), as well as specific
temperaments that may predispose individuals to develop-
ing a mood condition, another important and timely area of
emerging research (Singh et al.). The neurocognitive im-
pairment that is present in youth with bipolar disorder has
been addressed in a comprehensive meta-analysis (Joseph et
al.). There is also important research that attempts to char-
acterize the neuroendocrine abnormalities related to de-
pression and remission and relationships with sleep abnor-
malities (Rao et al.). Finally, two new studies investigate
whether early intervention for children at risk for bipolar dis-
order may be called for (Findling et al.) or test possible new
treatments for youth with ADHD and severe mood dysreg-
ulation (Waxmonsky et al.).
Part II will follow in the next issue. Some of the best minds
working in the field partnered on this effort, and we are hope-
ful that this will signal the start of a new time where the spe-
cific mechanisms involved in etiology and pathophysiology
of pediatric mood disorders will increasingly be unraveled.
We strongly believe that the best window for intervention for
these serious mental illnesses will be at the first few signs of
difficulty, or perhaps even before the signs of the illness are
present. We are living to see the time when mechanisms will
be known and specific interventions will be tested, hopefully
leading to a pronounced impact on the course of these dis-
eases, and resulting in improved outcomes.
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